TABLE 1.
Clinical comparison of the HHcy and non‐HHcy groups.
| Patient characteristicsa | Total (n = 123) | HHcy group (n = 41) | Non‐HHcy group (n = 82) | p Value |
|---|---|---|---|---|
| Mean age ± SD, years | 38.6 ± 10.5 | 39.0 ± 12.2 | 38.4 ± 9.6 | .781 |
| Female | 61 (49.6%) | 9 (22.0%) | 52 (63.4%) | .001 |
| Initial symptoms | ||||
| Asymptomatic | 2 (1.6%) | 1 (2.4%) | 1 (1.2%) | .568 |
| TIA | 52 | 18 (43.9%) | 35 (42.7%) | |
| Infarction | (43.1%) | 5 (12.2%) | 19 (23.2%) | |
| Hemorrhage | 24 (19.5%) | 10 (24.4%) | 16 (19.5%) | |
| Others (headache, epilepsy) | 26 (21.1%) | 7 (17.1%) | 11 (13.4%) | |
| Stroke risk factors | 18 (14.6%) | |||
| Hypertension | 51 | 21 (51.2%) | 30 (36.6%) | .120 |
| Diabetes mellitus | (41.5%) | 5 (12.2%) | 19 (23.2%) | .148 |
| Hyperlipidemia smoking or drinking | 24 (19.5%) | 19 (46.3%) | 38 (46.3%) | 1.000 |
| 13 (34.2%) | 11 (13.9%) | .011 | ||
| 57 (46.3%) | ||||
| 24 (20.5%) | ||||
| PCI | 60 (48.8%) | 18 (43.9%) | 42 (51.2%) | .444 |
| Admission mRS score | ||||
| 0 | 3 (2.4%) | 1 (2.4%) | 2 (2.4%) | .150 |
| 1 | 42 | 12 (29.3%) | 30 (36.6%) | |
| 2 | (34.1%) | 18 (43.9%) | 28 (34.1%) | |
| 3 | 46 | 4 (9.8%) | 18 (22.0%) | |
| 4 | (37.4%) 22 | 6 (14.6%) | 4 (4.9%) | |
| 5 | (17.9%) | 0 | 0 | |
| 6 | 10 (8.1%) | 0 | 0 | |
| 0 | ||||
| 0 |
HHcy: hyperhomocysteinemia; TIA: transient ischemic attack; PCI: posterior circulation involvement; mRS: modified Rankin Scale.
aValues are presented as the number of patients (%) unless otherwise noted.